Tevogen (TVGN) EPS (Diluted) (2022 - 2026)
Tevogen (TVGN) EPS (Diluted) (2022 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.15 |
| 10 | Tevogen | 27.32 Mn | 27.32 Mn | - | -1.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.52 |
| Mar 31, 2026 | -1.61 |
| Dec 31, 2025 | -1.45 |
| Sep 30, 2025 | -1.50 |
| Jun 30, 2025 | -1.53 |
| Mar 31, 2025 | -3.25 |
| Dec 31, 2024 | -3.21 |
| Sep 30, 2024 | -1.74 |
| Jun 30, 2024 | -1.97 |
| Mar 31, 2024 | 3.69 |
| Dec 31, 2023 | 230.74 |
| Sep 30, 2023 | -16.29 |
| Jun 30, 2023 | -0.62 |
| Mar 31, 2023 | 2.21 |
| Dec 31, 2022 | -0.34 |
| Sep 30, 2022 | 0.56 |
| Jun 30, 2022 | 0.07 |
| Mar 31, 2022 | -0.03 |